Vestibular schwannomas constitute approximately 6% of intracranial tumors.
Apart from the association with neurofibromatosis-2 (NF-2), where a defect
in chromosome 22 has been identified, the pathogenesis of sporadic vestibul
ar schwannomas is largely unknown. Very few studies have explored the role
of neurotrophic growth factors in vestibular schwannoma. The objective of t
his study is to evaluate for the presence and pattern of EPO and EPO-R expr
ession within vestibular schwannomas. Our hypothesis that erythropoietin (E
PO) and erythropoietin receptor (EPO-R) were expressed in vestibular schwan
nomas was based on a recent report of rapid growth of a vestibular schwanno
ma in a patient undergoing preoperative EPO treatment. Using immunohistoche
mistry, we have demonstrated that both EPO and EPO-R are expressed in a maj
ority of these tumors.